BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 3, 2022
View Archived Issues
New animal models reveal potential topical therapies for congenital nevi
Read More
RGS16 impacts CD8+ T-cell exhaustion and limits therapy efficacy
Read More
New Rho kinase 2 inhibitors identified at Medshine Discovery
Read More
Hongyun Biotech presents new MAP4K1 inhibitors
Read More
Guangzhou Henovcom Bioscience discovers autotaxin inhibitors
Read More
New lysophosphatidic acid receptor 1 antagonists patented by Humanwell Healthcare
Read More
RIKEN presents new immunostimulants
Read More
Tau-targeting therapy reduces epilepsy and autism behaviors in model of Dravet syndrome
Read More
FDA accepts IND for novel oral immune checkpoint inhibitor, TT-816
Read More
Chimeric switch-receptor PD1-DAP10-41BB augments NK92 cell antitumor activity
Read More
SHH expression is required for bone regeneration in a murine model
Read More
Long in the making changes lead to tipping point in blood stem cells
Read More
MARCH8 attenuates cGAS-mediated innate autoimmune responses
Read More
Nitrase Therapeutics announces expansion of pipeline to include oncology programs
Read More
Janux Therapeutics' JANX-007 to advance into clinical development
Read More
